| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |